Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

An international research team led by the Medical University of Vienna has shown that continuous glucose monitoring (CGM) in ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Continuous glucose monitors were originally designed to help people with diabetes track and better manage their blood sugar (aka ‘blood glucose’). Nowadays, not everyone you see wearing one actually ...

A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology. Continuous glucose monitors, ...

PreEvnt isaac device uses breath analysis to monitor glucose levels without needles, drawing attention at CES 2026 as a ...

By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said the U.S. Patent and Trademark Office issued three patents for its ...

Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until recently, CGM use had been ...

Investing.com -- Glucotrack Inc. (NASDAQ:GCTK) stock surged 60% Thursday after the company announced that the U.S. Patent and ...

Letitia explains how a small medical device, designed to help manage the illness, is now blamed for sending hundreds of ...

Add Yahoo as a preferred source to see more of our stories on Google. This image provided by Abbott’s Lingo division in July 2025, shows the Lingo wearable device for continuous glucose monitoring.